In defense of the corporate author for multicenter trials
作者： Curtis L. Meinert
DOI: 10.1016/0197-2456(93)90223-Z
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(7)
Morton F. Goldberg, Changes in the Archives Archives of Ophthalmology. ,vol. 111, pp. 39- 40 ,(1993) , 10.1001/ARCHOPHT.1993.01090010043023
Barbara S. Hawkins, Lee McCaffrey, Publication practices in NIH-sponsored multicenter clinical trials Controlled Clinical Trials. ,vol. 12, pp. 634- ,(1991) , 10.1016/0197-2456(91)90114-2
Jerome P. Kassirer, Marcia Angell, On Authorship and Acknowledgments New England Journal of Medicine. ,vol. 325, pp. 1510- 1512 ,(1991) , 10.1056/NEJM199111213252112
Miles J. Zaremski, The Editors Reply Law, Medicine and Health Care. ,vol. 10, pp. 38- 38 ,(1982) , 10.1111/J.1748-720X.1982.TB01698.X
Curtis L. Meinert, Clinical Trials: Design, Conduct, and Analysis ,(1986)
On authorship and acknowledgements. The New England Journal of Medicine. ,vol. 326, pp. 1085- ,(1992) , 10.1056/NEJM199204163261612
, Uniform Requirements for Manuscripts Submitted to Biomedical Journals New England Journal of Medicine. ,vol. 324, pp. 424- 428 ,(1991) , 10.1056/NEJM199102073240624